Inventor
NEELAMKAVIL SANTHOSH F
US13 patents
⚠️ This page may combine multiple inventors who share the name “NEELAMKAVIL SANTHOSH F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
9 patentsUS10123995B2Nov 13, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations72
US10093683B2Oct 9, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME4 citations71
US10081617B2Sep 25, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME2 citations70
US11161854B2Nov 2, 2021
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME2 citations68
US9676723B2Jun 13, 2017
Factor XIa inhibitors
MERCK SHARP & DOHME1 citations50
US9663527B2May 30, 2017
Factor XIa inhibitors
MERCK SHARP & DOHME1 citations50
US11174248B2Nov 16, 2021
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME0 citations49
US10214512B2Feb 26, 2019
Factor XIA inhibitors
MERCK SHARP & DOHME0 citations41
US9944643B2Apr 17, 2018
Factor XIa inhibitors
MERCK SHARP & DOHME0 citations36
MERCK SHARP & DOHME LLC
3 patentsUS12030872B2Jul 9, 2024
N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC2 citations69
US12319671B2Jun 3, 2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations48
US12540131B2Feb 3, 2026
N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations42